De novo SEs overlapping with CLL-specific CpG sites harbor many known genes with relevance in CLL biology (e.g., CD5, CLLU1, IRF2; Additional file 1: Figure S3b, Additional file 3: Table S2). Here, CLLU1 is linked to B-cell chronic lymphocytic leukemia.